Home > Insider Trading > Filing (0001181431-13-028429)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534287	Bioamber Inc.	BIOA.U	Industrial Organic Chemicals (2860)	980601045

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1575786	Denis Lucquin	C/O Sofinnova Partners 17 Rue De Surene Paris I0 75008		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-14	880,000	$0.00	3,802,780	No	4	P	Indirect	Sofinnova Capital VI FCPR

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Sofinnova Capital VI FCPR

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2013-05-14	880,000	$0.00	440,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
880,000	2013-08-08	2017-05-09	No	4	P	Indirect

Footnotes

The reported securities are included within 880,000 Units purchased by Sofinnova Capital VI FCPR on May 14, 2013 for $10.00 per Unit in connection with the Issuer's initial public offering. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock.
The reporting person is a Managing Director of Sofinnova Capital VI FCPR, the owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.